Introductory Course for Biologics Development and Manufacturing completes training of 138 participants from 25 countries

The International Vaccine Institute (IVI) successfully completed the ‘2022 Introductory Course for Biologics Development and Manufacturing’ on July 29 to train

Related Keywords

Tunisia ,Seoul ,Soult Ukpyolsi ,South Korea ,South Africa ,Malaysia ,Nigeria ,Republic Of Korea ,Korea ,Nicaise Ndembi ,Rohaida Hashim ,Samia Rourou ,Samsung Biologics ,Everest Okeakpu ,Alice Lee ,Korea University College Of Medicine ,National Institute Of Health ,World Health Organization ,Yonsei University ,Seoul National University ,Laboratory Practice ,Korean Ministry Of Health ,Ministry Of Health Malaysia ,Head Of The Science Office ,Introductory Course For Biologics Development ,International Vaccine Institute ,Biovaccine Nigeria ,College Of Pharmacy ,Biologics Development ,Global Training Hub ,Korean Ministry ,Sartorius Korea ,Korea University College ,Biotech Development Lab ,Institute Pasteur Tunisia ,National Institute ,Korean Minster ,Closing Ceremony ,African Vaccine Manufacturing ,Africa Centres ,Disease Control ,Science Office ,Chief Operating Officer ,Biovaccine Nigeria Limited ,Introductory Course ,Bio Intensive Training Courses ,Standard Practice ,Gxp Course ,Good Clinical ,Introductory Course For Standard Practice Gxp ,